Neuralstem (CUR) Posts Quarterly Earnings, Misses Estimates By $0.03 EPS
Neuralstem (NYSE:CUR) posted its quarterly earnings results on Friday. The company reported ($0.08) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.05) by $0.03, Stock Ratings Network.com reports.
Neuralstem (NYSE:CUR) traded up 8.91% during mid-day trading on Friday, hitting $3.30. The stock had a trading volume of 755,225 shares. Neuralstem has a 52 week low of $1.43 and a 52 week high of $4.81. The stock’s 50-day moving average is $3.54 and its 200-day moving average is $3.72. The company’s market cap is $286.3 million.
CUR has been the subject of a number of recent research reports. Analysts at Aegis reiterated a “buy” rating on shares of Neuralstem in a research note on Friday.
Neuralstem, Inc is a development-stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stems cells and the use of small molecule drugs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.